Search results for "From ACP Internist"
No additional benefit seen for self-monitored blood glucose with community health worker support
In a small trial, patients with insulin-treated diabetes were randomly assigned to usual care, a lottery incentive for daily self-monitored blood glucose, or the lottery plus support from a community health worker if needed.
https://diabetes.acponline.org/archives/2022/06/10/6.htm
10 Jun 2022
New insulins present benefits, challenges
The July/August ACP Internist summarizes expert advice on treating diabetes with new types of insulin.
https://diabetes.acponline.org/archives/2016/07/15/7.htm
15 Jul 2016
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients age 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://diabetes.acponline.org/archives/2023/04/14/6.htm
14 Apr 2023
ADA, EASD update guidance on managing hyperglycemia
An updated consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) addressed social drivers of health, lifestyle modifications, and new drug classes for type 2 diabetes.
https://diabetes.acponline.org/archives/2022/10/14/7.htm
14 Oct 2022
Text messages may improve glycemic control in patients with diabetes and coronary disease
Patients in a Chinese study received six automated text messages per week with educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle.
https://diabetes.acponline.org/archives/2019/09/13/9.htm
13 Sep 2019
GLP-1 analogues may be associated with bile duct, gallbladder disease
Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral antidiabetic drugs, but an increased risk was seen with use of GLP-1 analogues.
https://diabetes.acponline.org/archives/2016/08/12/7.htm
12 Aug 2016
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://diabetes.acponline.org/archives/2020/02/14/7.htm
14 Feb 2020
Targeting social needs may help improve type 2 diabetes outcomes, review finds
A systematic review found that HbA1c levels were improved significantly by food supplementation with referral and diabetes support, financial incentives with education and skills training, housing relocation with counseling support, and the integration of nonmedical interventions into medical care.
https://diabetes.acponline.org/archives/2022/07/08/6.htm
8 Jul 2022
Antihypertensives associated with worse outcomes in diabetic patients with lower SBP
Blood pressure treatment goals should be less aggressive in people with diabetes than without diabetes, study authors said, because if systolic blood pressure (SBP) is already less than 140 mm Hg, additional agents might be harmful.
https://diabetes.acponline.org/archives/2016/03/11/7.htm
11 Mar 2016
Score may help predict which patients are likely to achieve type 2 diabetes cure after bariatric surgery
DiaRem, a weighted score ranging from 0 to 22 points, is based on age, insulin dependence, diabetes medication use, and HbA1c level.
https://diabetes.acponline.org/archives/2016/05/13/6.htm
13 May 2016